Extracellular volume fraction (ECV) derived from pre-operative computed tomography predicts prognosis in patients undergoing transcatheter aortic valve implantation (TAVI).
Davide VignaleAnna PalmisanoChiara GnassoDavide MargonatoDavide RomagnoloSimone BarbieriGiacomo IngallinaStefano StellaMarco Bruno AnconaMatteo MontorfanoFrancesco MaisanoEustachio AgricolaErnesto Di CesarePublished in: European heart journal. Cardiovascular Imaging (2023)
In this prospective observational cohort study, ECV measured at TAVI planning CT predicts the composite endpoint (HFH or death) in high-risk severe AS patients.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve
- ejection fraction
- computed tomography
- aortic valve replacement
- patients undergoing
- transcatheter aortic valve replacement
- end stage renal disease
- positron emission tomography
- newly diagnosed
- magnetic resonance imaging
- dual energy
- contrast enhanced
- prognostic factors
- left ventricular
- early onset
- peritoneal dialysis
- coronary artery disease
- magnetic resonance
- pet ct